News Snapshot:
Shanghai exchange suspends Syngenta’s China IPO Syngenta Group’s planned $10 billion (CHF9.3 billion) initial public offering (IPO) in China has been postponed due to missing financial information from the agrichemical giant, the Shanghai Stock Exchange said on Monday. This content was published on October 11, 2021 - 11:10 State-owned ChemChina bought the Basel-based Swiss agriscience group Syngenta for $44 billion in 2017. ChemChina’s application to list on Shanghai’s STAR Market was accepted at the start of July and was widely expected to be the world’s largest flotation this year. The STAR market suspended 57 applications on September 30, citing a...
